Springer Nature
Browse
12890_2019_889_MOESM2_ESM.docx (17.21 kB)

Additional file 2: of Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma

Download (17.21 kB)
journal contribution
posted on 2019-07-18, 04:24 authored by Mattis Gottlow, David Svensson, Ilya Lipkovich, Monika Huhn, Karin Bowen, Peter Wessman, Gene Colice
Parameter modifications applied to the SIDES algorithm. (DOCX 17 kb)

Funding

AstraZeneca

History

Usage metrics

    BMC Pulmonary Medicine

    Categories

    Keywords

    AsthmaIL-13Predictive biomarkerSIDES (subgroup identification based on differential effect search)STRATOS 1STRATOS 2Subgroup identificationTralokinumab (up to 10)

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC